Parkinson’s Disease (PD) is a degenerative disorder of the central nervous system that affects close to one million Americans.  PD is a chronic and progressive disorder, which is thought to be caused by the destruction of dopamine (an important neurotransmitter) that generates cells in the midbrain.  The cause of PD is unknown and there is no cure.  Treatment is focused on medication and management of symptoms. Current research includes investigations into new animal models of the disease, and of the potential use of gene therapy, stem cell transplants and neuro-protective agents. There is hope that mesenchymal stem cells will mitigate some of the degenerative effects.  We have developed a specific deployment protocol that attempts to utilize the regenerative properties of stromal vascular fraction (SVF), which is rich in mesenchymal stem cells and growth factors. Special measures are taken to optimize transport of SVF across the blood-brain barrier to improve central nervous system uptake. This is completed in an outpatient setting at the time of SVF harvesting and procurement. The entire procedure takes approximately three hours.


2519 Avenue O
Brooklyn, NY 11210


200 Chambers Street
New York, NY 10007